3413 results

Useful links in Interventional Cardiology

12 Oct 2016

We would like to share useful information and links to resources with you on Interventional Cardiology, medical professional societies, specialised websites and scoring tools.

Major LBTs from EuroPCR 2025 - Meta-Analysis of individual patient data from the PROTECTED TAVR and BHF PROTECT-TAVI studies

22 May 2025 – From EuroPCR 2025

Stroke remains one of the most feared complications of TAVI—for both patients and physicians. In this EuroPCR 2025 video interview, Bernard Prendergast and Rajesh Kharbanda examine the role of cerebral protection during TAVI procedures, in light of two randomised trials: PROTECTED TAVR and BHF PROTECT-TAVI. While...

EuroPCR 2025: Late-breaking data demonstrate sustained significantly lower event rates with Elixir Medical’s DynamX® Bioadaptor over drug-eluting stent through three Years

21 May 2025

Shockwave Medical study confirms benefit of IVL-first strategy in real-world female patients with complex calcified lesions in late-breaking data presentation at EuroPCR 2025

20 May 2025

PCR Tokyo Valves 2026: registration fees

05 Jan 2026

Choose below your registration option!

⚠️ Registration alert: for your security, please use the official platform to register for PCR Tokyo Valves. PCR Courses cannot be held responsible for any issues encountered when using alternative means.

The official currency for all purchases is the Japanese yen. All prices are displayed...

Tendyne transcatheter mitral valve system in patients with severe mitral annular calcification: one-year outcomes from the SUMMIT Severe MAC cohort

27 Oct 2025

Luigi Biasco interviews Paul Sorajja about the SUMMIT MAC Pivotal Trial he presented at TCT 2025, in San Francisco.

Author

Luigi Biasco

Author

Paul Sorajja

Sirolimus-eluting iron bioresorbable scaffold in coronary artery disease: two-year results of IRONMAN-II randomised controlled trial

25 Oct 2025

Alex Sticchi interviews Lei Song on the IRONMAN II trial he presented at TCT 2025, in San Francisco.

Author

Alessandro Sticchi

Author

Lei Song

Surgical left atrial appendage occlusion in VHD without AF: OPINION Trial

03 Sep 2025

Alex Sticchi provides his take on the results of the OPINION trial presented by Yang Wang at the ESC Congress 2025 in Madrid.

Author

Alessandro Sticchi

Randomised comparison of intravascular lithotripsy vs. cutting balloon treatment in calcified coronary artery disease – The Short-CUT trial

27 Oct 2025

Aaysha Cader provides her take on the Short-CUT trial presented by Suzanne J. Baron at TCT 2025, in San Francisco.

Author

Aaysha Cader

The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation

01 Sep 2025

Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.

Author

Chiara De Biase

TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome

03 Sep 2025

Aaysha Cader provides her take on TACSI presented by Anders Jeppsson at ESC Congress 2025 in Madrid.

Author

Aaysha Cader

Comparison of drug-coated versus conventional balloons for treatment of side branches of bifurcation lesions: the OCVC-BIF study

29 Oct 2025

Ali Nazmi Calik provides his take on the OCVC-BIF study presented by Takayuki Ishihara at TCT 2025, in San Francisco.

Author

Ali Nazmi Calik

TARGET-FIRST: Early aspirin discontinuation after PCI in low-risk acute MI patients

01 Sep 2025

Elad Asher provides his take on the results of TARGET-FIRST presented by Giuseppe Tarantini at the ESC Congress 2025 in Madrid.

Author

Elad Asher

A randomised, multicenter, non-inferiority comparison of intravascular lithotripsy and super-high-pressure non-compliant balloons for treatment of calcified and refractory coronary lesions - The VICTORY trial

27 Oct 2025

Mirvat Alasnag provides her take on the VICTORY trial presented by Matthias Bossard at TCT 2025 in San Francisco.

Author

Mirvat Alasnag

STRIVE: intracoronary low-dose recombinant tissue plasminogen activator in primary PCI for STEMI and large thrombus burden

25 Oct 2025

Elad Asher provides his take on the STRIVE study presented by Shamir R. Mehta at TCT 2025, in San Francisco.

Author

Elad Asher

Stratified treatment of myocardial infarction with non-obstructive coronary arteries: the PROMISE trial

31 Oct 2025

Nicola Ryan provides her take on the PROMISE trial presented by Rocco Antonio Montone at TCT 2025, in San Francisco.

Author

Nicola Ryan

DAPT-SHOCK-AMI trial: Cangrelor in cardiogenic shock

03 Sep 2025

Kalaivani Mahadevan and Fizzah Choudry provide their take on DAPT-SHOCK-MI presented by Zuzana Motovska at ESC Congress 2025 in Madrid.

Author

Fizzah Choudry

Author

Kalaivani Mahadevan

Percutaneous coronary intervention of native coronary artery versus saphenous vein graft in patients with prior coronary artery bypass graft surgery (PROCTOR)

03 Nov 2025

Kalaivani Mahadevan and Trisha Singh provide their take on the PROCTOR study presented by Ruben de Winter at TCT 2025, in San Francisco.

Author

Kalaivani Mahadevan

Author

Trish Singh

TOP-CABG: the timing of platelet inhibition after coronary artery bypass grafting trial

02 Sep 2025

Jonathan Curio provides his take on TOP-CABG, presented by Xin Yuan at ESC Congress 2025 in Madrid.

Author

Jonathan Curio

Percutaneous transseptal transcatheter mitral valve replacement using a dedicated balloon-expandable valve: 1-year outcomes from the ENCIRCLE trial using the SAPIEN M3

27 Oct 2025

Jonathan Curio provides his take on the ENCIRCLE Trial presented by David Daniels at TCT 2025 in San Francisco.

Author

Jonathan Curio